<DOC>
	<DOCNO>NCT03000413</DOCNO>
	<brief_summary>Despite scientific evidence could support use ketamine adult patient undergo acute bronchospasm require mechanical ventilation ( MV ) , ketamine largely employed setting . The aim study therefore assess definitively real benefit use ketamine patient severe bronchospasm , require ICU stay need MV order establish refute use drug `` standard therapy '' case .</brief_summary>
	<brief_title>Ketamine Efficacy Acute Severe Bronchospasm ICU : MACANUDO Trial</brief_title>
	<detailed_description />
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Bronchial Spasm</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<mesh_term>Fentanyl</mesh_term>
	<criteria>patient acute exacerbation COPD status asthmaticus , undergo controlled mechanical ventilation acute bronchospasm , define airway resistance value ( Rsr max ) great 12 , use inhale therapy bronchodilator systemic corticosteroid patient require use continuous intravenous sedation optimization ventilation contraindication history previous adverse event use study drug diagnostic potential Rsr increase cause bronchospasm ( bronchial obstruction , acute respiratory distress syndrome adult , pulmonary fibrosis )</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>